← USPTO Patent Applications

LAMOTRIGINE SALTS, CO-CRYSTALS, AND COMPOSITIONS

Application US20260083745A1 Kind: A1 Mar 26, 2026

Assignee

Azurity Pharmaceuticals Ireland Limited

Inventors

Jordan R. Hunt, Gerold Mosher, Paras P. Jain, Krishna Mohan Lakshmipathula

Abstract

The invention discloses a lamotrigine oral suspension and a preparation method thereof, the lamotrigine oral suspension is composed of lamotrigine and other pharmaceutic adjuvants, the pharmaceutic adjuvants are composed of a suspending aid, a wetting agent, a bacteriostatic agent, a flavoring agent, a defoaming agent, a pH regulator and a solvent, and the wetting agent is hydroxypropyl methylcellulose, glycerin, Tween 80 and the like. According to the invention, the suspending aid is adopted to increase the liquid viscosity and improve the stability of the suspension, and the wetting agent is adopted to improve the hydrophobicity of API, so that the stability and redispersibility of the suspension are improved, and the preparation process is simple and suitable for industrial mass production.

CPC Classifications

A61K 31/53 C07C 57/15 C07D 253/075

Filing Date

2025-02-14

Application No.

19053770